Pilot Study of Bortezomib and Dexamethasone Pre- and Post-Risk-Adapted Autologous Stem Cell Transplantation in AL Amyloidosis

Treatment for AL amyloidosis aims to eradicate clonal plasma cells, thereby disrupting the amyloid deposition causing organ damage. Risk-adapted high-dose melphalan plus autologous stem cell transplantation (RA-ASCT) is an effective therapy. We conducted a prospective pilot analysis of a comprehensi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Main Authors: Landau, Heather, Lahoud, Oscar, Devlin, Sean, Lendvai, Nikoletta, Chung, David J., Dogan, Ahmet, Landgren, C. Ola, Giralt, Sergio, Hassoun, Hani
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6953746/
https://ncbi.nlm.nih.gov/pubmed/31446197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.08.016
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares